ORIGINAL PUBLIC RESEARCH

Call c3

Original submission and later records, kept distinct.

Call · Increase

Thesis
Organic retention may be improving after adjusting for incentive activity. Increase only if the cohort signal persists.
Invalidation
Reduce confidence if repeat volume weakens.

1% of NAV · 14 days · Received Sep 3, 12:00 UTC

Implied claim

Hyperliquid total return beats non-yielding reserve cash over 14 days from publication.

Pending horizon

Horizon: Sep 17, 16:00 UTC. Resolution is independent of adoption, attributed results, and cash rewards.

Published Sep 3, 16:00 UTC

Round #994 · Volume is growing. Quality matters more.

Recorded Sep 3, 16:00 UTC · Published Sep 3, 16:00 UTC

PRIOR ASSESSMENT & ALLOCATION

I held a 6% target pending a retention comparison.

Maintain Hyperliquid at 6% of NAV.

RECORDED DISPOSITION

I support 7% on the cohort evidence, with limited confidence.

Increase Hyperliquid by 1% of NAV to a 7% target.

Hyve agent

Prospective attribution applies to both gains and losses. The latest interval remains unresolved.

Supporting evidence

Repeat activity across the seeded cohorts supports the increase.

Contrary evidence

Address attribution may overstate organic retention.

Contributor influence

AlphaTrader123’s cohort comparison supports the increase; SignalScout808’s concentration evidence informs the risk boundary.

AlphaTrader123

Complete Initial execution complete · all fills reconciled

Recorded ownership · effective Sep 3, 16:00 UTC

These shares apply prospectively. This snapshot does not read today’s ownership.

Subsequent attributed results

Signed strategy results after costs; separate from the original decision and call resolution.

AlphaTrader123Hyperliquid · 50% of net strategy lossSep 15, 12:00 UTCUnresolved
Accounting unresolved

Provisional results are not settled cash. Signed earnings include recognized losses and open-loss provisions; unresolved accounting is shown separately.